ID: ALA3981481

Max Phase: Preclinical

Molecular Formula: C29H31F3N8O2

Molecular Weight: 580.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1cnc2c(-c3ccc(OCCC4CCN(CC(=O)N5CCC(C#N)CC5)CC4)c(C(F)(F)F)c3)nc(C#N)nc21

Standard InChI:  InChI=1S/C29H31F3N8O2/c1-38-18-35-27-26(36-24(16-34)37-28(27)38)21-2-3-23(22(14-21)29(30,31)32)42-13-8-19-4-9-39(10-5-19)17-25(41)40-11-6-20(15-33)7-12-40/h2-3,14,18-20H,4-13,17H2,1H3

Standard InChI Key:  KKKMPHQHBOLXFF-UHFFFAOYSA-N

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctss Cathepsin S (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 580.62Molecular Weight (Monoisotopic): 580.2522AlogP: 4.16#Rotatable Bonds: 7
Polar Surface Area: 123.96Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.92CX LogP: 3.26CX LogD: 2.63
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.41Np Likeness Score: -1.31

References

1.  (2016)  Nitrogen-containing bicyclic aromatic heterocyclic compound, 

Source

Source(1):